Introduction: Epilepsy is the third most common neurological disorder worldwide, following stroke and Alzheimer's disease. Generally, the recommended effective dose of anticonvulsants was enough in attaining seizure control in 70-80% of the patients. However, there are also occasions where patients who are on stable regimen of anticonvulsants associated with breakthrough seizure either induced directly by hypocalcaemia or resulting from chronic kidney failure induced hypocalcaemia. Current paper presents the therapeutic approach for breakthrough seizure secondary to hypocalcaemia in the case of an adolescent with chronic kidney failure.Case narrative: An epileptic male adolescent was admitted due to fitting lasted for 1 minute, followed by postictal drowsiness. Laboratory tests revealed optimal therapeutic range of Sodium Valproate serum concentration, but low serum calcium level. Hence, calcium replacement therapy was given as the main management plan. Discussion: It is recommended that hypocalcaemia with neurological manifestations, without the underlying cause, should be managed with parenteral calcium. In chronic kidney failure patient, oral calcium and vitamin D should be started as soon as practical and maintained even after discharged. Whereas, anticonvulsants should be reserved only for persistent seizure even after correction of calcium level.
Conclusion:The management of breakthrough seizure should be individualised depending on clinical data and general condition of the patients.